These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression. Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E Mod Pathol; 2020 Jun; 33(6):1033-1040. PubMed ID: 31896811 [TBL] [Abstract][Full Text] [Related]
7. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England. Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430 [TBL] [Abstract][Full Text] [Related]
8. Malignant transformation in a cohort of patients with oral epithelial dysplasia. Hankinson PM; Mohammed-Ali RI; Smith AT; Khurram SA Br J Oral Maxillofac Surg; 2021 Nov; 59(9):1099-1101. PubMed ID: 34303542 [TBL] [Abstract][Full Text] [Related]
9. Profiling cancer risk in oral potentially malignant disorders-A patient cohort study. Thomson PJ; Goodson ML; Smith DR J Oral Pathol Med; 2017 Nov; 46(10):888-895. PubMed ID: 28833670 [TBL] [Abstract][Full Text] [Related]
10. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients. Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209 [TBL] [Abstract][Full Text] [Related]
12. Recurrence and malignant transformation rates of high grade oral epithelial dysplasia over a 10 year follow up period and the influence of surgical intervention, size of excision biopsy and marginal clearance in a UK regional maxillofacial surgery unit. Gilvetti C; Soneji C; Bisase B; Barrett AW Oral Oncol; 2021 Oct; 121():105462. PubMed ID: 34303087 [TBL] [Abstract][Full Text] [Related]
13. Interventional laser surgery: an effective surgical and diagnostic tool in oral precancer management. Thomson PJ; Wylie J Int J Oral Maxillofac Surg; 2002 Apr; 31(2):145-53. PubMed ID: 12102411 [TBL] [Abstract][Full Text] [Related]
15. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. Hsue SS; Wang WC; Chen CH; Lin CC; Chen YK; Lin LM J Oral Pathol Med; 2007 Jan; 36(1):25-9. PubMed ID: 17181738 [TBL] [Abstract][Full Text] [Related]
16. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study. von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919 [TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia]. Gao Y; Guo ZL; Luo HY; Wang J Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571 [TBL] [Abstract][Full Text] [Related]
18. Interventional laser surgery for oral potentially malignant disorders: a longitudinal patient cohort study. Thomson PJ; Goodson ML; Cocks K; Turner JE Int J Oral Maxillofac Surg; 2017 Mar; 46(3):337-342. PubMed ID: 27866683 [TBL] [Abstract][Full Text] [Related]
19. Abnormal p53 Immunohistochemical Patterns Shed Light on the Aggressiveness of Oral Epithelial Dysplasia. Novack R; Zhang L; Hoang LN; Kadhim M; Ng TL; Poh CF; Kevin Ko YC Mod Pathol; 2023 Jul; 36(7):100153. PubMed ID: 36906072 [TBL] [Abstract][Full Text] [Related]